is tirzepatide a glp-1 agonist Understand GLP-1/GIP Dual and Its Effect on Current Weight Loss Therapy Tirzepatide vs Semaglutide: Key Differences,
Description
A robust pipeline of entero-pancreatic hormone-based therapies is currently in development, with several dual and triple agonists expected to emerge for obesity in the coming years
Future Directions Tirzepatide represents just the beginning of multi-agonist approaches
We use cookies to make your experience better
You must follow program requirements, including medication use and regular check-ins, for the full nine months
J Endocrinol (1993) 138(1):15966
Annals of Internal Medicine, 2025
